Acquisition delivers industry-leading research capability, and strengthens pipeline with a novel candidate for ulcerative colitis, Crohn’s disease and other autoimmune conditions
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
The British-Swedish pharma major certainly has a strong competitive edge for BTC treatment in the country
36.4% of patients with diabetic neuropathic pain in 2021 were completely treatment refractory and would benefit from new treatment options.
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
Pluvicto and Scemblix launches are progressing well and we are awaiting data in earlier lines of therapy.
Transformation to pure-play Innovative Medicines company nears completion
The WAVEsystem with the WAVEcontrol 4.0 embedded
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
Subscribe To Our Newsletter & Stay Updated
